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Abstract 
At physiological p asma concentrations, retinoic acid (RA) cannot cross the blood-testis barrier formed by Sertoli and peritubular cells, 
and it is thought to be mainly synthesized in situ through the oxidation of retinol. We have thus examined the in vitro RA biosynthetic 
capacity of cultured Sertoli and peritubular cells isolated from the seminiferous tubules of prepubertal rats, using holo-cellular retinol 
binding protein (CRBP) as a sabstrate. Although both somatic ell types contain CRBP and retinoic acid nuclear receptors, RA synthesis 
was only detected with Sertoli cell subcellular f actions. Most of the RA synthesizing activity of these cells is contributed by a 
microsomal-cytosolic system that shares many functional similarities with a RA biosynthetic pathway originally identified in rat liver. RA 
synthesis is maximal at a time of postnatal life (20 days) preceding meiotic cell accumulation a d remains nearly constant thereafter. The 
unique ability of Sertoli cell subcellular f actions to support RA formation from holoCRBP, along with the observed age-dependent 
modulation of this activity, indicate that Sertoli cells represent the main site of intratubular RA production and that they may play a key 
role in controlling RA-dependent processes within the seminiferous tubule. 
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1. Introduction 
Vitamin A is essential for mammalian reproduction. In 
rats fed a vitamin A deficient diet (VAD animals), germ 
cell development s ops at early meiosis and detachment of
immature cells occurs ([1]., and references therein). Sper- 
matogenesis is restored by retinol (vitamin A alcohol), but 
not retinoic acid (RA) diet~u3~ supplementation [1,2]. How- 
ever, the intraperitoneal injection of high doses of RA, the 
active metabolite of vitamin A, also induces the reinitiation 
of the spermatogenic process in VAD rats [3]. The high 
RA dosage that is required to restore spermatogenesis may 
thus, at least in part, reflect the reduced ability of this 
retinoid to cross the blood-testis barrier formed by Sertoli 
and peritubular cells. 
Abbreviations: CRBP, cellular retinol binding protein; CRABP, cellu- 
lar retinoic acid binding protein; MEM, minimal essential medium; RA, 
retinoic acid; RAId, retinaldehyde; RAR, retinoic acid receptor; RXR, 
retinoid X receptor; RBP, retinol binding protein; SCOC, Sertoli cell only 
culture; VAD, vitamin A deficient. 
* Corresponding author. Fax: +39 521 905151; e-mail: 
simone@irisbioc.bio.unipr.it. 
Besides forming the junctional complexes that limit free 
access to the seminiferous epithelium, the somatic cells 
that surround the seminiferous tubules cooperate in the 
secretion of the intercellular matrix and in various other 
testicular functions, including uptake of retinol from the 
plasma retinol binding protein (RBP) [1,4-7]. Both cell 
types contain nuclear etinoic acid receptors (RARs) [8-10] 
and relatively high levels of cellular etinol binding protein 
type I (CRBP I) [11-13], while the cytosolic binding 
protein for RA (CRABP I) has only been detected in 
Sertoli cells [13]. The expression of CRBP, as well as of 
other secretory products in Sertoli cells is positively regu- 
lated by retinoids, and most of these effects are likely to be 
mediated by the RA-dependent activation of RARs [1,14- 
17]. 
Since the RA content of the testis is almost independent 
from the plasma levels of this retinoid [18], the endoge- 
nous production of RA assumes a particular elevance for 
the proper maintenance of vitamin A-dependent processes 
in the seminiferous tubules. In various in vitro systems, 
including rat testis cytosolic extracts [19] and cultured 
Sertoli cells [20], free retinol has previously been found to 
serve as a substrate for the NAD-dependent formation of 
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RA by cytosolic dehydrogenases. However, in view of the 
high levels of CRBP in the somatic ells of the seminifer- 
ous tubules [1 l-13], unbound retinol is not a likely physio- 
logical precursor of RA. The retinol-CRBP complex has 
recently been shown to support in vitro RA synthesis by 
either an as yet uncharacterized NAD-dependent cytosolic 
dehydrogenase [21,22], or by a mixed system in which 
retinaldehyde g nerated by a microsomal retinol dehydro- 
genase (NADP-dependent) is oxidized to RA by a soluble 
aldehyde dehydrogenase (NAD-dependent) [20,23]. Both 
activities have been detected in subcellular fractions from 
whole testis [21,23]. Nothing is known, however, about he 
relative importance of these two RA synthesizing systems 
in controlling intratubular retinoic acid homeostasis, nor 
about their age-dependent modulation, or distribution 
among the somatic cells of the seminiferous tubule that 
have access to the plasma retinol-RBP complex. 
As an initial step toward a better understanding of RA 
metabolism in a system which almost entirely relies on the 
endogenous ynthesis of this vitamin A derivative, we 
have used the retinol-CRBP I complex as a substrate to 
analyze the in vitro RA synthesizing capacity of rat Sertoli 
and peritubular cells. 
days in MEM (w/o serum) before utilization. Microscopi- 
cally, peritubular cells isolated and cultured in this way 
[13] appeared to be homogeneous with no evident contami- 
nation by other somatic ell types. 
2.2. Subcellular fractionation 
After gentle detachment with a rubber policeman, cells 
were centrifuged at 350 X g (10 min), resuspended in 0.25 
M sucrose, 10 mM Hepes (pH 7.4), plus 2.5 mM 2-mer- 
captoethanol, 0.5 mM DTT, 0.5 mM EDTA, leupeptin (10 
Ixg/ml), aprotinin (10 txg/ml), and homogenized with 15 
strokes in an ice-cooled Dounce homogenizer. The ho- 
mogenate was then centrifuged at 25000 x g for 10 min, 
and the resulting supernatant was further centrifuged at 
105000 X g for 1 h to separate a cytosolic supernatant 
from a microsomal pellet. Microsomes were finally resus- 
pended in a minimal volume of homogenization buffer, 
and the protein content of both subcellular fractions was 
determined with the method of Bradford [26] using bovine 
serum albumin as a standard. 
2.3. Preparation of  recombinant rat CRBP I 
2. Experimental procedures 
2.1. Isolation and culture of  somatic cells 
Unless otherwise specified in the text, somatic cells 
were isolated from the testes of prepubertal (18- to 20-day- 
old) Wistar rats as described previously [24]. Briefly, 
testicular fragments were digested with trypsin to detach 
the interstitium and, after rinsing with Hank's buffer, the 
tubules were treated with collagenase, washed twice with 
the same buffer, and fragmented by gentle pipetting. The 
resulting suspension was then centrifuged at 30 X for 2 
min, and the cell pellet was resuspended in 10 volumes of 
Minimum Essential Medium (MEM, Gibco, Grand Island, 
NY) before plating at the desired cell density. A mono- 
layer of Sertoli cells usually formed after 3 days of culture 
(32°C), and cells were cultured for two more days before 
being harvested. These cultures were judged to contain 
almost pure Sertoli cells by light microscopy [24], with 
less than 10% contamination by other cell types. When 
required, residual contaminating germ cells were removed 
as previously described [25]. 
Peritubular cells were derived from the collagenase 
supernatant generated during Sertoli cell preparation. This 
fraction was combined with the first Hank's washing, 
centrifuged at 50 X g for 5 min, and the resulting super- 
natant was further centrifuged at 350 X g for 10 min. 
Peritubular cells from this pellet were finally resuspended 
in MEM containing 10% fetal calf serum, plated, and 
cultured at 37°C. A monolayer of peritubular cells usually 
formed within 3 days, and cells were cultured for 2 more 
Rat CRBP I was expressed in Escherichia coli (strain 
JM101) using the pMON-CRBP vector [27] (a gift of Dr. 
Marc Levin, Washington University, St. Louis, MO) and 
purified to near homogeneity by gel filtration, followed by 
anion exchange FPLC as previously described [22,27]. The 
holo-form of CRBP I was prepared with the same proce- 
dure, except that the recombinant protein was saturated 
with all-trans retinol (50 IxM) immediately after bacterial 
cell lysis and before each chromatographic step. 
2.4. Retinoic acid synthesis assays 
Reaction mixtures were assembled into polypropylene 
(2.5 ml) microcentrifuge tubes and incubated for 30 min at 
37°C, under subdued illumination, in a final volume of 200 
ILl. Assays were carried out in duplicate, and contained 
150 mM KC1, 50 mM Hepes (pH 8.0), 2 mM DTT, 0.5 
I~M leupeptin, plus NAD and NADP (2 mM each), cytoso- 
lic (200 txg total protein) and microsomal (100 p~g total 
protein) subcellular fractions, and 4 IxM retinol-CRBP, 
with or without an equimolar amount of apoCRBP, as 
specified in the text. Cytosolic RA synthesis was assayed 
under similar conditions (200 Ixg of cytosolic protein, 2 
mM NAD) as described previously [22]. Assays without 
cofactors were used as controls. 
2.5. Extraction and HPLC analysis of  retinoids 
Reactions were blocked and immediately processed for 
HPLC analysis by the ethyl acetate-methyl acetate xtrac- 
tion procedure of Heyman et al. [28]. HPLC analyses were 
carried out isocratically, using a Waters 6000A solvent 
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delivery system fitted with a Rheodyne injection valve and 
a 500 Ixl loop, at a flow rate of either 0.7 ml/min, or 1.5 
ml/min in the case of solvent A and B (see below), 
respectively. Elution was monitored at 350 nm for RA, and 
at 383 nm for retinaldehyde, using a Waters 484 tunable 
absorbance detector. A Novapak C18 (30 × 4.6 mm, Wa- 
ters, Milford, MA) or a Hypersyl 5 ODS (250 X 4.6 mm, 
Shandon Scientific, Cheshire, UK) column was used as a 
stationary phase with solvent A or B, respectively. Solvent 
A consisted of water/methanol (19:81 v /v)  containing 
0.01 M ammonium acetate, and it was used to resolve 
different isomeric forms of RA (retention times for the 
13-cis, 9-cis and all-trans isomers were, respectively, 14.5, 
16.5 and 18 min); solvent B contained acetonitrile/water 
(70:30 v /v)  plus 0.01 M sodium acetate, and it was 
routinely utilized for the determination of all-trans RA, 
retinol and retinaldehyde (retention times of 4.5, 18 and 25 
min, respectively). The amounts of newly synthesized 
retinaldehyde and RA were quantitated by comparison 
with the corresponding standard curves; the sensitivity of 
detection was at least 1 pmol. All-trans retinol and RA 
were from Fluka (Buchs, Switzerland), all-trans retinalde- 
hyde and 13-cis RA standards were from Sigma (St. Louis, 
MO), 9-cis RA was a k;ind gift of Hoffman-LaRoche 
(Prodotti Roche, Milan, Italy); the purity of all retinoids 
was checked by HPLC. 
3. Results and discussion 
3.1. Retinoic acid synthesis by subcellular fractions from 
cultured Sertoli cells 
Two distinct pathways for the synthesis of RA from 
holoCRBP have previously been demonstrated in liver 
[20-23]. Considering the prominent role played by Sertoli 
cells in the retinoid-regulated synthesis of various secre- 
tory products for developing erm cells, we initially exam- 
ined microsomal and cytosolic fractions derived from pri- 
mary cultures of prepubertal Sertoli cells for their ability to 
support retinoic acid synthesis from holoCRBP. As shown 
in Table 1, using in vitro assay conditions previously 
applied to liver subcellular fractions and a holoCRBP 
concentration exceeding the apparent K m values measured 
in the liver system, both activities could be detected. The 
rate of RA formation by the mixed system, however, was 
about 8-fold higher than the rate of conversion measured 
in the presence of cytosol only, and the amounts of RA 
produced by the cytosolic and mixed activities from Sertoli 
cells were, respectively, 10- and 2-fold reduced as com- 
pared to those measured in parallel experiments carried out 
with equivalent amounts of subcellular f actions from liver 
(not shown). As revealed by control experiments con- 
ducted with subcellular fractions derived from freshly iso- 
lated Sertoli cells, the levels of both RA synthesizing 
Table 1 
Retinoic acid synthesizing capacity of the cytosolic and the mixed 
systems of Sertoli cells a 
apo CRBP Subcellular Retinoic 
fraction(s) acid (pmol) 
- cytosol 2.3 + 0.4 
- microsomes-cytosol 16.2 + 2.8 
+ cytosol ND 
+ microsomes-cytosol 5.8 + 0.7 
a Assays were carried out as described under Experimental procedures in 
the presence of 4 I~M recombinant retinol-CRBP, and either cytosol (200 
Ixg total protein), or microsomes plus cytosol (200 tzg total protein each). 
Equimolar amounts of apoCRBP (4 I.tM) were added as indicated; 
subcellular fractions of cultured Sertoli cells isolated from 20-day-old 
animals were utilized as sources of RA synthesizing activity. As previ- 
ously reported for the liver system [29], under the conditions of these in 
vitro assays, microsomes strongly interfere with the cytosolic reaction, 
whose contribution to the RA output of the mixed system becomes 
negligible. Data are the average of at least three independent experiments; 
ND, not detectable (less than 1 pmol of RA formed). 
activities did not appreciably change as a consequence of
in vitro culture (5 days; data not shown). 
In various retinoid-responsive cells, the concentration f 
cellular retinol binding protein exceeds the concentration 
of unesterified retinol [30], and excess apoCRBP has previ- 
ously been shown to negatively modulate both cytosolic 
RA formation [20-22], as well as retinaldehyde oxidation 
by the soluble NAD-dependent dehydrogenase of the mixed 
biosynthetic system [31]. Sertoli cells have a relatively 
high CRBP content (see below), and though the total level 
of testis CRBP has previously been shown to decrease in 
VAD animals [32], it is still conceivable that the relative 
amounts of apo- and holo-binding protein may also change 
in response to variations of the vitamin A status. We thus 
determined the effect of excess apoCRBP on RA synthesis 
supported by distinct subcellular fractions from Sertoli 
cells. As shown in Table l, the RA biosynthetic activity of 
both systems considerably decreases in the presence of 
equimolar amounts of holo and apoCRBP. Under these 
conditions, RA synthesis by the cytosolic system falls 
below detection, while it is about hree-fold reduced in the 
case of the mixed system. Therefore in Sertoli cells, 
regardless of the actual ratio between apo and holoCRBP, 
the RA synthesizing activity of the mixed system quantita- 
tively exceeds that of the cytosolic dehydrogenase(s). 
3.2. Characterization of retinoic acid synthesis by the 
microsomal-cytosolic system of Sertoli cells 
To verify that a microsomal-cytosolic system similar to 
that originally identified in liver [23] is indeed responsible 
for RA synthesis by subcellular fractions from Sertoli 
cells, and to set out linear in vitro assay conditions to be 
used for subsequent experiments, we analyzed various 
reaction parameters that may affect this activity. In the 
presence of an equimolar mixture of holo and apoCRBP 
(i.e., under conditions that minimize the amount of free 
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retinol in equilibrium with holoCRBP), and a constant 
amount of cytosolic protein, RA synthesis linearly re- 
sponded to increasing amounts of microsomes, yielding 
about 7 pmol of RA at saturation (Fig. 1A). Product 
formation at 37°C was maximal at pH 8.0, it proceeded 
linearly, with no detectable lag, for about 90 min, and 
increased with increasing amounts of microsomes and 
cytosol at a 1:2 ratio (data not shown). As shown in Fig. 
1 A, intermediate r tinaldehyde (RAId) tends to accumulate 
in the presence of excess microsomes, a characteristic 
feature of the mixed biosynthetic system. However, unlike 
the in vivo situation where retinaldehyde has never been 
found in nonocular tissues [33], sizeable amounts of micro- 
some-generated retinaldehyde were consistently detected 
among the products of the in vitro reaction, even at 
suboptimal microsomes:cytosol ratios. We next examined 
the cofactors requirement of the reaction, by systematically 
omitting either one or both of the two coenzymes. As 
shown in Fig. 1B, RA synthesis by the Sertoli cell mixed 
system strictly depends on an exogenous supply of cofac- 
tors. Similarly to the preferential coenzyme requirement of
the liver system [20], retinaldehyde and retinoic acid syn- 
thesis are maximal, respectively, in the presence of NADP, 
and NADP plus NAD, but sizeable amounts of either 
product were also formed in reactions upplemented with a 
single coenzyme (Fig. IB). In addition, as previously 
reported for liver microsomes [23], variably low amounts 
of RA were detected in reaction mixtures supplemented 
with microsomes only (see Fig. 2 legend), and this contri- 
bution was subtracted from the total RA output of microso- 
mal-cytosolic reactions. 
Data reported in Fig. I C show that under the conditions 
utilized for most of our experiments, RA synthesis by the 
mixed system from Sertoli cells becomes aturated at a 
holoCRBP concentration slightly higher than 4 IxM. At 
saturation, the rate of RA formation is 73 pmol/h per mg 
of cytosolic protein, and an about 3-fold higher maximum 
specific activity was obtained in the absence of excess 
apoCRBP. Interestingly, the saturating concentration of 
holoCRBP measured in these experiments, though possibly 
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Fig. 1. Characterization of retinoic acid synthesis by the microsomal-cytosolic system from cultured Sertoli cells. (A) Retinoic acid synthesis from 
retinol-CRBP (4 IxM holoCRBP plus an equimolar amount of apoCRBP) in the presence of a fixed amount of cytosol (200 I~g total protein) and increasing 
amounts of microsomes as indicated. (B) Cofactors requirement for RA synthesis; equal concentrations of NAD and/or NADP (2 mM each) were used. 
(C) holoCRBP concentration dependence of RA synthesis; assays (45 min, 37°C) were carded out with increasing concentrations of an equimolar mixture 
of holo and apoCRBP. (D) HPLC analysis of the isomeric onfiguration of in vitro produced retinoic acid; arrows indicate the elution times of various RA 
isomers (l 3c: 13-cis RA, 9c: 9-cis RA, At: all-tram RA); an identical distribution of RA isomers was obtained upon mock-incubation a d extraction of an 
authentic all-trans RA standard. Unless otherwise specified (panel A), assays were conducted as described under Experimental Procedures, using Sertoli 
cell subcellular f actions (100 Ixg of microsomal protein plus 200 t~g of cytosolic protein) obtained from 20-day-old animals. Data reported in panels A -C  
are the mean + S.D. of at least three independent experiments; a representative chromatogram is shown in panel D. 
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overestimated due to the presence of excess apoCRBP, is 
in the same range of the concentration f CRBP in Sertoli 
cells (1-9 I~M) - as calculated from previously reported 
values for the amounts of CRBP and the volume of Sertoli 
cells [6,13,34], assuming a fractional cytosolic volume of 
50%. 
The isomeric configuration of in vitro synthesized RA 
was finally determined (Fig. 1D). This analysis was moti- 
vated by the recent discovery of RXRs, a distinct family of 
nuclear RA receptors that selectively bifid the 9-cis isomer 
of RA and are expressed in a variety of tissues, including 
rat testis [35]. The mode of formation of this particular RA 
isomer is still unclear, and it was thus conceivable that 
some 9-cis RA isomer could be generated, either syntheti- 
cally or post-synthetically, in the microsomal-cytosolic 
system of Sertoli cells. We found, however, that all of the 
in vitro produced RA is in l:he all-trans form, and the other 
two minor isomeric species (9-cis and 13-cis RA) which 
are visible in the representative HPLC chromatogram re- 
ported in Fig. 1D proved[ to be generated by artificial 
isomerization of all-trans RA during organic solvent ex- 
traction. 
3.3. Subcellular fractions from peritubular cells do not 
support in vitro retinoic acid synthesis 
Peritubular cells, the other somatic cell type of the 
seminiferous tubule, also contain CRBP, at levels even 
higher than Sertoli cells [13], and they thus represent 
another potential site of RA synthesis. Rather surprisingly, 
however, even under the most favorable assay conditions 
(i.e., in the presence of a stoichiometric retinol-CRBP 
complex) no RA synthesis was detected with either combi- 
nation of subcellular fractions derived from cultured per- 
itubular cells of 12-day or 20-day-old animals (data not 
shown). Given the sensitivity limit of our HPLC analysis, 
this result implies that if there is any RA production in 
peritubular cells, it must be lower than 10 pmol/h per mg 
of protein (i.e., at least 20-fold reduced as compared to the 
maximum specific activity measured with Sertoli cell sub- 
cellular fractions). 
The latter finding prompted us to determine whether the 
apparent inactivity of the mixed biosynthetic system from 
peritubular cells derives from a selective deficiency of 
either the microsomal or the cytosolic omponent, or from 
the lack of both. To distinguish between these two possi- 
bilities, we tested the ability of either cytosolic (Fig. 2A) 
or microsomal (Fig. 2B) fractions from peritubular cells to 
reconstitute RA synthesizing activity in combination with 
complementary f actions from Sertoli cells. Liver subcellu- 
lar fractions obtained from the same group of animals were 
utilized as positive controls for this experiment. Under 
conditions in which both heterologous combinations of 
Sertoli cell and liver subcellular f actions yielded an effec- 
tive complementation (Fig. 2), practically no net RA syn- 
thesis was observed when either cytosol or microsomes of 
peritubular cells were mixed with complementary f actions 
from liver (not shown) or Sertoli cells (Fig. 2). The 
apparent biosynthetic incompetence of both subcellular 
fractions from peritubular cells may reflect either a nega- 
tive artifactual effect associated to the in vitro system, or 
an inherently very low biosynthetic capacity of peritubular 
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Fig. 2. Heterologous complementation a alysis of the retinoic acid biosynthetic capacity of subcellular fractions isolated from cultured peritubular cells. 
(A) Retinoic acid synthesis in reaction mixtures containing Sertoli cell microsomes plus either homologous, or heterologous cytosolic fractions as 
indicated. Net values for the amounts of RA produced by the mixed system are reported; they were obtained after subtraction of the amount of RA 
(1.5 + 0.4 pmol) produced in control reactions not supplemented with cytosol. (B) Retinoic acid synthesis by Sertoli cell cytosol plus either homologous, 
or heterologous microsomal fractions was assayed as in (A). The amounts of RA generated in parallel reactions upplemented with microsomes only 
(1.5 + 0.4, ND, and 2.5 + 0.6, four Sertoli cells, peritubular cells and liver microsomes, respectively) were subtracted from the total amount of RA produced 
by the complete system in each of the corresponding assays. Standard assay conditions, and subcellular fractions prepared in parallel from prepubertal 
animals were utilized for these experiments; data are the mean 5: S.D. of three independent experiments. 
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cells. The fact, however, that these data were obtained by 
independent assays of the activities associated to two 
distinct subcellular fractions favours the latter possibility, 
and makes it unlikely that the lack of activity of peritubu- 
lar cell preparations imply results from the artifactual 
destruction of both the microsomal and the cytosolic com- 
ponent of the mixed biosynthetic system upon homoge- 
nization. In keeping with this view, preliminary experi- 
ments carried out on intact somatic cells have shown that 
endogenous RA is undetectable in peritubular cells (as 
opposed to approximately 3 pmol of RA/100  mm plate in 
the case of Sertoli cells), and that the rate of RA synthesis 
from free retinol is severely reduced (about 50-fold) in 
peritubular as compared to Sertoli cells (D. Cavazzini, 
unpublished). 
Though unexpected, the lack of any detectable RA 
synthesizing activity in peritubular cells is on the same line 
as their recently reported incompetence for retinol esterifi- 
cation [7]. Our finding thus further illustrates the very 
peculiar case of cells which are actively involved in retinol 
internalization [7] and have a relatively high CRBP content 
[13], yet are apparently unable to carry out any efficient 
metabolic onversion of the retinol they take up from the 
blood. Unlike retinyl esters, however, retinoic acid is a 
necessary prerequisite for CRBP expression [36], and 
RARa has been detected in peritubular cells [9]. There- 
fore, although our present data do not exclude the possibil- 
ity that trace amounts of RA are either taken up by, or 
synthesized in, peritubular cells, the greatly reduced RA 
synthesizing capacity of these cells compared to Sertoli 
cells also suggests the possible existence in the seminifer- 
ous tubule of a complex retinoid transport network, 
whereby part of the retinol delivered to Sertoli cells [7] is 
returned to peritubular cells as retinoic acid. 
3.4. Age-dependent variation of  the retinoic acid biosyn- 
thetic actiL'i~ of  Sertoli cells 
During early postnatal life, Sertoli cells increase both in 
size and number until about 15 days of age, while the 
subsequent growth of the testis is primarily due to germ 
cell proliferation. Within this range of time, CRBP, 
CRABP, as well as nuclear retinoic acid receptors and 
other Sertoli cell proteins, have previously been found to 
exhibit rather distinctive temporal patterns of expression 
[1,8-10,12,37,38]. We were thus interested to determine 
whether the RA biosynthetic apacity of the microsomal- 
cytosolic system of cultured Sertoli cells also varies as a 
function of age. As revealed by in vitro assays conducted 
under linear reaction conditions, RA synthesizing activity 
increased about 5-fold between postnatal (p.n.) day 12 and 
20, and remained nearly constant hereafter (Fig. 3). By 
comparison, the liver RA biosynthetic activity of animals 
belonging to the same age groups exhibited a substantially 
different age dependence, remaining essentially constant 
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Fig. 3. Levels of retinoic acid biosynthetic a tivity in Sertoli cells isolated 
from animals of different postnatal ges. Retinoic acid synthesis by the 
microsomal-cytosolic system of Sertoli cells was assayed inthe presence 
(striped bars) or in the absence ( mpty bars) of excess apoCRBP. Data 
reported as 34/SCOC (Sertoli Cell Only Culture) were obtained with 
cultured Sertoli cells (34-day-old animals) that were deprived of the 
associated germ cells [25] prior to subcellular fractionation. Assays were 
carried out under standard eaction conditions, using equal amounts (total 
protein) of subcellular f actions prepared from cultured Sertoli cells 
isolated from animals of different postnatal ges. Reaction mixtures 
contained either the stoichiometric etinol-CRBP complex (4 ixM, empty 
bars) or an equimolar mixture of apo and holoCRBP (4 IxM each, striped 
bars); data re the mean ___ S.D. of three replicates. 
until p.n. day 37, and increasing about two-fold thereafter 
(data not shown). 
The most prominent event taking place in rat testis 
around p.n. day 20 is the onset of meiosis, suggesting that 
the increase of RA synthesizing activity in Sertoli cells 
may reflect an augmenting demand for RA concomitant 
with this transition. On the other hand, considering the rise 
of the germ cell population which sets out at this time of 
postnatal life, one could also imagine that germ cells in the 
cultures significantly contribute to the observed increase of 
RA synthesis. This does not appear to be the case, how- 
ever, since RA synthesizing activity is maximal at an early 
time of the meiotic transition (p.n. day 20), and is subse- 
quently maintained at about the same level notwithstand- 
ing the ongoing accumulation of germ cells. In addition, 
subcellular fractions of Sertoli cells (from either 20-day or 
34-day-old animals) subjected to a hypotonic treatment 
which selectively destroys germ cells [25], supported es- 
sentially identical levels of RA synthesis as untreated 
Sertoli cells (Fig. 3, cf. 34 days and 34 days/SCOC, and 
data not shown). Therefore, Sertoli cells, rather than asso- 
ciated germ cells present in the cultures, are primarily 
responsible for the increase of retinoic acid synthesizing 
activity that has been detected at p.n. day 20. 
4. Conclusions 
Sertoli cells support germ cell proliferation and differ- 
entiation through the secretion of a variety of products, the 
D. Cm'azzini et al. / Biochimica et Biophysica Acta 1313 (1996) 139-145 145 
synthesis of many of which is positively controlled by 
retinoids [1]. These cells have the ability to esterify retinol 
taken up from the retino]t-RBP complex [5,6], and, as 
shown by the present work, they also have the capacity to 
utilize some of the internalized retinol for all-trans RA 
synthesis. Most of the RA synthesizing activity of Sertoli 
cells is contributed by a microsomal-cytosolic system that 
can operate at different relative levels of apo and 
holoCRBP, and shares marly functional similarities with a 
RA biosynthetic pathway originally identified in rat liver 
[23]. The unique ability of Sertoli cell subcellular f actions 
to support RA formation indicates that these cells represent 
the main site of endogenous retinoic acid production in the 
seminiferous tubules. Along this view, the observed age- 
dependent modulation of their RA synthesizing activity 
suggests a novel role of Sertoli cells in controlling retinoic 
acid-dependent processes within the seminiferous tubule. 
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